menu search

Neurocentria Announces Dr. Thomas Südhof to Join the Scientific Advisory Board

Neurocentria Announces Dr. Thomas Südhof to Join the Scientific Advisory Board
The appointment further strengthens the company’s scientific resources, including in neuronal function and synaptic transmission, which are central to Neurocentria’s approach for developing novel therapies for neurodegenerative and neuropsychiatric disorders. WALNUT CREEK, Calif., Jan. 13, 2023 (GLOBE NEWSWIRE) — Neurocentria, Inc., a privately held late-stage biotechnology company developing novel therapies for neurodegenerative and neuropsychiatric disorders, […] The post Neurocentria Announce... Read More
Posted: Jan 13 2023, 14:00
Author Name: forextv
Views: 110765

Search within

Pages Search Results: